Drug Shortage Report for ESTALIS 250/50 MCG
| Report ID | 257753 |
| Drug Identification Number | 02241837 |
| Brand name | ESTALIS 250/50 MCG |
| Common or Proper name | ESTALIS 250/50 MCG |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ESTRADIOL NORETHINDRONE ACETATE |
| Strength(s) | 50MCG 250MCG |
| Dosage form(s) | PATCH |
| Route of administration | TRANSDERMAL TRANSDERMAL |
| Packaging size | 8TTSM |
| ATC code | G03FA |
| ATC description | PROGESTOGENS AND ESTROGENS IN COMBINATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-05-19 |
| Estimated end date | 2025-08-15 |
| Actual end date | 2025-08-18 |
| Shortage status | Resolved |
| Updated date | 2025-08-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2025-08-19 | English | Compare |
| v10 | 2025-08-18 | French | Compare |
| v9 | 2025-08-18 | English | Compare |
| v8 | 2025-08-11 | French | Compare |
| v7 | 2025-08-11 | English | Compare |
| v6 | 2025-07-14 | French | Compare |
| v5 | 2025-07-14 | English | Compare |
| v4 | 2025-07-14 | French | Compare |
| v3 | 2025-07-14 | English | Compare |
| v2 | 2025-05-20 | French | Compare |
| v1 | 2025-05-20 | English | Compare |
Showing 1 to 11 of 11